PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
34681595-1	2021	We report a lymphoma patient with profound B-cell deficiency after chemotherapy combined with anti-CD20 antibody successfully treated with remdesivir and convalescent plasma for prolonged SARS-CoV-2 infection.	remdesivir	139-149	keratin 20	Homo sapiens	99-103	
35426564-0	2022	Remdesivir in Coronavirus Disease 2019 patients treated with anti-CD20 monoclonal antibodies: a case series.	remdesivir	0-10	keratin 20	Homo sapiens	66-70	
35426564-2	2022	We aim to present our experience with remdesivir treatment in anti-CD20-treated patients with prolonged symptoms, a patient population for which no data from randomized controlled trials are available.	remdesivir	38-48	keratin 20	Homo sapiens	67-71	
35426564-3	2022	METHODS: From the beginning of the pandemic until February 2021, we included all consecutive patients from our healthcare network on anti-CD20 treatment with prolonged COVID-19 symptoms, who received remdesivir.	remdesivir	200-210	keratin 20	Homo sapiens	138-142